Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • B vs MRNA✓SelectedUSD · MRNAB vs MRNA performance historyLatest closeAs of-0.66%11/13
Stock and ETF performance explorer

B vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+230.8%
MRNA return
+915.3%
Excess return
-684.5%
Maximum drawdown
-53.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.7%-3.4%+2.8%-0.5%
7D-7.3%-12.1%+4.8%-6.7%
30D-3.3%-1.3%-2.0%-3.3%
3M-7.8%+250.9%-258.7%-17.1%
6M-15.5%+343.0%-358.6%-25.3%
YTD-12.3%+657.4%-669.7%-24.6%
1Y+5.4%+794.9%-789.5%-10.2%
3Y+165.5%+218.1%-52.6%+132.3%
5Y+107.0%-3.4%+110.4%+86.8%
All+230.8%+915.3%-684.5%+167.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling